HYBRID EVENT: You Can Participate In Person At Los Angeles, USA Or Virtually From Your Home Or Work
ICOACD · Registering as Listener

International Congress on Ophthalmology and Corneal Disorders

21–22 Oct 2026 Los Angeles, USA Standard / Physical Participation
Listener Registration
$169
virtual · $259 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply
Try FAST10 for 10% off on eligible registrations.

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to info@isit.org.in with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to info@isit.org.in.
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track will explore cutting-edge technologies and methodologies in ocular diagnostics, focusing on advancements in imaging techniques and biomarker identification. Participants will discuss the implications of these innovations for early detection and management of ocular diseases.
This session will highlight recent clinical research findings related to corneal disorders, including keratoconus and corneal dystrophies. Emphasis will be placed on novel therapeutic approaches and their clinical applications.
This track will address the latest developments in the understanding and management of retinal diseases, including age-related macular degeneration and diabetic retinopathy. Discussions will focus on innovative treatment strategies and patient-centered care.
This session will cover the latest research and clinical practices in glaucoma management, including pharmacological and surgical interventions. Participants will examine the effectiveness of new therapies and the importance of personalized treatment plans.
This track will focus on the latest surgical techniques in cataract surgery, including phacoemulsification and femtosecond laser-assisted surgery. Outcomes, complications, and patient satisfaction will be key areas of discussion.
This session will explore various vision rehabilitation strategies for individuals with visual impairments, emphasizing the role of multidisciplinary approaches. Participants will share evidence-based practices that enhance quality of life for patients.
This track will highlight the importance of translational research in bridging the gap between laboratory findings and clinical applications in ophthalmology. Topics will include the development of novel therapies and the role of clinical trials.
This session will address the unique challenges faced in pediatric ophthalmology, including congenital disorders and developmental delays. Innovative approaches to diagnosis and treatment will be discussed to improve outcomes in children.
This track will explore emerging trends in vision science, including neuro-ophthalmology and the impact of systemic diseases on ocular health. Participants will discuss the implications of these trends for future research and clinical practice.
This session will focus on the latest advancements in ocular pharmacology, including drug delivery systems and novel therapeutic agents. Discussions will emphasize the importance of pharmacogenomics in personalized medicine for ocular conditions.
This track will examine the intersection of public health and ophthalmology, focusing on strategies to address global eye health disparities. Participants will discuss the role of community outreach and education in preventing ocular diseases.